QuidelOrtho Sustainability Profile
QuidelOrtho Corporation, a leading player in the diagnostics industry, is headquartered in the United States and operates extensively across North America and Europe. Founded in 1979, the company has achieved significant milestones, including the merger of Quidel Corporation and Ortho Clinical Diagnostics, which enhanced its market position and product offerings. QuidelOrtho specialises in innovative diagnostic solutions, focusing on areas such as infectious disease testing, women's health, and blood typing. Their core products, including rapid diagnostic tests and laboratory instruments, are distinguished by their accuracy and speed, catering to the evolving needs of healthcare providers. With a strong commitment to quality and innovation, QuidelOrtho has established itself as a trusted name in the diagnostics sector, recognised for its contributions to improving patient outcomes globally.
DitchCarbon Score
How does QuidelOrtho's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
QuidelOrtho's score of 30 is higher than 50% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
QuidelOrtho's reported carbon emissions
In 2023, QuidelOrtho reported total carbon emissions of approximately 22,544,000 kg CO2e for Scope 1 and about 29,690,000 kg CO2e for Scope 2 (market-based). This reflects a decrease from 2022, where emissions were approximately 26,212,000 kg CO2e for Scope 1 and about 28,369,000 kg CO2e for Scope 2 (market-based). The company has disclosed emissions data for both Scope 1 and Scope 2 but has not reported any Scope 3 emissions. Despite the absence of specific reduction targets or initiatives, QuidelOrtho is committed to sustainability and actively participates in industry climate initiatives. The emissions data is not cascaded from any parent organisation, indicating that these figures are solely representative of QuidelOrtho's operations. The company continues to focus on reducing its carbon footprint as part of its broader climate commitments.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2022 | 2023 | |
|---|---|---|
| Scope 1 | 26,212,000 | 00,000,000 |
| Scope 2 | 28,369,000 | 00,000,000 |
| Scope 3 | - | - |
How Carbon Intensive is QuidelOrtho's Industry?
How Carbon Intensive is QuidelOrtho's Location?
QuidelOrtho's Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
QuidelOrtho has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
GenMark Diagnostics, Inc.
Let us know if this data was useful to you
Usage Policy
You're welcome to quote or reference data from this page, but please include a visible link back to this URL.
Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.